Accessibility Menu
 
Sino Biopharmaceutical logo

Sino Biopharmaceutical

(OTC) SBHMY

Current Price$14.29
Market Cap$12.77B
Since IPO (2017)+86%
5 Year-25%
1 Year+53%
1 Month-10%

Sino Biopharmaceutical Financials at a Glance

Market Cap

$12.77B

Revenue (TTM)

$30.57B

Net Income (TTM)

$3.87B

EPS (TTM)

$0.35

P/E Ratio

40.25

Dividend

$0.23

Beta (Volatility)

0.06 (Low)

Price

$14.29

Volume

36

Open

$14.29

Previous Close

$14.29

Daily Range

$14.29 - $14.29

52-Week Range

$9.48 - $20.16

SBHMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sino Biopharmaceutical

Industry

Pharmaceuticals

Employees

21,435

CEO

S Y Tse

Headquarters

Wan Chai, HK

SBHMY Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

22%

Net Income Margin

7%

Return on Equity

7%

Return on Capital

14%

Return on Assets

3%

Earnings Yield

2.48%

Dividend Yield

1.61%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.77B

Shares Outstanding

893.84M

Volume

36

Avg. Volume

11.266

Financials (TTM)

Gross Profit

$25.41B

Operating Income

$6.63B

EBITDA

$7.78B

Operating Cash Flow

$9.29B

Capital Expenditure

$1.70B

Free Cash Flow

$7.59B

Cash & ST Invst.

$22.56B

Total Debt

$16.08B

Sino Biopharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$8.79B

+10.7%

Gross Profit

$7.25B

+11.2%

Gross Margin

82.47%

N/A

Market Cap

$12.77B

N/A

Market Cap/Employee

$523.75K

N/A

Employees

24,379

N/A

Net Income

$1.69B

+12.3%

EBITDA

$1.98B

+0.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$6.89B

+43.2%

Accounts Receivable

$7.87B

+58.4%

Inventory

$2.26B

-4.9%

Long Term Debt

$7.65B

+267.8%

Short Term Debt

$8.42B

+9.3%

Return on Assets

3.08%

N/A

Return on Invested Capital

13.69%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNMSFGenmab A/S
$258.12-4.22%
WXXWYWuXi Biologics (Cayman) Inc.
$8.29-1.78%
WXIBFWuXi Biologics (Cayman) Inc.
$4.18+0.00%
IVBXFInnovent Biologics, Inc.
$10.34-0.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$13.85+0.02%
INTCIntel
$119.84+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.26+0.04%
ACHRArcher Aviation
$6.36+0.04%

Questions About SBHMY

What is the current price of Sino Biopharmaceutical?

Sino Biopharmaceutical is trading at $14.29 per share.

What is the 52-week range for Sino Biopharmaceutical?

Over the past 52 weeks, Sino Biopharmaceutical has traded between $9.48 and $20.16.

How much debt does Sino Biopharmaceutical have?

As of the most recent reporting period, Sino Biopharmaceutical reported total debt of $2.30B.

How much cash does Sino Biopharmaceutical have on hand?

Sino Biopharmaceutical reported $1.06B in cash and cash equivalents in its most recent financial results.

What is Sino Biopharmaceutical’s dividend yield?

Sino Biopharmaceutical currently has a dividend yield of 1.61%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.